Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000571

Drug Information
SynonymsD08130; Lisdexamfetamine (INN); MolPort-004-285-960; CID11597698; UNII-H645GUL8KJ; DB01255; LS-187377; Lisdexamfetamine; 608137-32-2; NRP104    
Trade NameVyvanse    
CompanyNew River Pharmaceuticals    
IndicationAttention deficit hyperactivity disorderApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassCentral Nervous System Agents    
CAS NumberCAS 608137-32-2
PubChem Compound IDCID 11597698.    
PubChem Substance IDSID 16843305.    
TargetAlpha-1B adrenergic receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021977 To Reference
Ref 2Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543